Immunogenicity and impact on disease activity of influenza and pneumococcal vaccines in systemic lupus erythematosus: a systematic literature review and meta-analysis
Mathilde Pugès(Hôpital Pellegrin), P. Duffau(Centre National de la Recherche Scientifique), P. Biscay(Clinique Mutualiste de l'Estuaire), Christophe Richez(Boston University), Noémie Gensous(Centre National de la Recherche Scientifique), Thomas Barnetche(Université de Bordeaux), Estibaliz Lazaro(Centre National de la Recherche Scientifique), Julien Sénéschal(Université de Bordeaux), Marie‐Elise Truchetet(Centre National de la Recherche Scientifique)
Cited by 80
Related Papers
Trial of Anifrolumab in Active Systemic Lupus Erythematosus
|New England Journal of Medicine|2019|1.3k
<i>MUC5B</i> Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease
|New England Journal of Medicine|2018|501
Further characterization of clinical and laboratory features in VEXAS syndrome: large‐scale analysis of a multicentre case series of 116 French patients*
|British Journal of Dermatology|2021|414
European Dermatology Forum S1‐guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes
|Journal of the European Academy of Dermatology and Venereology|2017|261